2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Ventricular Septal Defect: new trials by email Literature Review of Ventricular Septal Defect trials Research Report on Ventricular Septal Defect
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Regional Anesthesia Following Pediatric Cardiac Surgery Regional Anesthesia, Wound infiltration, Ropivacaine 0.2% Injectable Solution - Atrial Septal Defect, Ventricular Septal Defect | Phase 4 | Completed | Duke University | 52 | 2023-03-29 | 2025-08-28 |
| The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects. Salbutamol, Norflouran (Placebo Evohaler(R) ) - Ventricular Septal Defect | Phase 4 | Completed | University of Aarhus | 96 | 2016-10-15 | 2018-07-05 |
Heart Septal Defects, Ventricular (2) · Heart Defects, Congenital (1) · Heart Septal Defects, Atrial (1) · Pain, Procedural (1)
Cardiovascular Abnormalities (2) · Cardiovascular Diseases (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Heart Diseases (2) · Heart Septal Defects (2) · Heart Defects, Congenital (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Albuterol (1) · Anesthesia, Conduction (1) · Ropivacaine (1)
Duke University (1) · University of Aarhus (1)
Denmark (1) · United States (1)
Lisa M Einhorn, MD (1) · Vibeke E Hjortdal, MD PhD DMSc (1)